[ad_1]
Research has found that an experimental flu drug can completely halt coronavirus transmission within 24 hours, Europa Press reported.
It’s called MK-4482 / EIDD-2801, better known as “molnupiravir,” and it can be effectively involved in fighting the virus and its spread up to the large-scale supply of COVID-19 vaccines, writes DarikNews.
The study was conducted by a team of researchers from the Institute of Biomedicine at the University of Georgia, USA.
“This is the first demonstration of an oral drug that can rapidly block the transmission of SARS-CoV-2, which may be a game changer,” the researchers said in a publication in the scientific journal Nature Microbiology.
The characteristics of the drug, which can be taken orally, allow treatment to start early, which facilitates its effectiveness in various directions, including delaying the development of a serious disease in the patient. This can shorten the infectious phase to alleviate the emotional and socioeconomic consequences of possible prolonged isolation of the patient and rapidly suppress local foci of infection.
The researchers conducted tests on ferrets, a species they consider an appropriate transmission pattern due to their ability to spread the virus, and found that once the drug was administered, they did not transmit the disease to the animals that were with them in a single cage.
[ad_2]
